• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

Stenocare

1.00 DKK+4.17 %10.7. klo 17.55
Less than 1K followers

STENO

First North Denmark

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+4.17 %
-8.26 %
-8.26 %
-40.12 %
-32.43 %
+83.15 %
-58.56 %
-85.72 %
-92.67 %

Stenocare is a Danish supplier of medical cannabis. Stenocare is the first player to have started sale of medical cannabis-based oils in Denmark. The company is now looking towards further European markets for its products. Stenocare is based in Randers, Denmark.

Read more
Market cap
43.4M DKK
Turnover
81.11K DKK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
EPS and dividend
Financial calendar
20.8.
2026

Interim report Q2'26

29.10.
2026

Interim report Q3'26

All
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Press release03.07.2026 klo 20.37

STENOCARE completes integration of CannGros ApS

Stenocare
Regulatory press release07.05.2026 klo 09.00

STENOCARE: Interim report first quarter 2026

Stenocare
Regulatory press release29.04.2026 klo 16.21

STENOCARE: Communiqué from Annual General Meeting

Stenocare

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release07.04.2026 klo 18.45

Notice to Annual General Meeting in STENOCARE A/S

Stenocare
Regulatory press release26.03.2026 klo 09.17

STENOCARE A/S publishes Annual Report 2025

Stenocare
Regulatory press release26.02.2026 klo 09.00

STENOCARE: Interim report fourth quarter and Financial Statement Release 2025

Stenocare
Press release11.02.2026 klo 09.00

STENOCARE A/S positions for First-Mover Advantage in France With Strategic Partnership, Product Filing, and National Distribution Partnership

Stenocare
Press release27.01.2026 klo 17.27

STENOCARE: Stenocare Kicks Off Strategic Partnership with WEECO to Launch New Astrum Oil Product in Germany

Stenocare
Regulatory press release30.12.2025 klo 12.19

Trading in STENOCARE shares by closely related party to board member

Stenocare
Press release21.11.2025 klo 07.41

BioStock: Stenocare acquires Canngros

Stenocare
Press release19.11.2025 klo 20.56

STENOCARE share analyst's comments on the CannGros acquisition

Stenocare
Regulatory press release18.11.2025 klo 10.59

STENOCARE: Correction of total shares issued and total nominal share capital:

Stenocare
Regulatory press release17.11.2025 klo 18.56

STENOCARE A/S acquires CannGros ApS and add DKK 4-6 million in annual revenue and supports 2026 break even goal

Stenocare
Regulatory press release17.11.2025 klo 18.01

STENOCARE A/S acquires CannGros ApS and add DKK 4-6 million in annual revenue and supports 2026 break even goal

Stenocare
Regulatory press release22.10.2025 klo 09.00

STENOCARE: Interim report third quarter 2025

Stenocare
Regulatory press release27.08.2025 klo 22.30

Trading in STENOCARE shares by closely related party to board member

Stenocare
Regulatory press release21.08.2025 klo 09.00

STENOCARE: Interim report second quarter 2025

Stenocare
Third party research19.05.2025 klo 11.05

STENOCARE: Time to Capitalize on STENOCARE 3.0 - Analyst Group

STENOCARE A/S (“STENOCARE” or the “Company”) is a medical cannabis trading company with products approved and available for patients in six countries. The Company has recently launched a premium product, Astrum oil, which Analyst Group sees as an important...

Stenocare
Regulatory press release15.05.2025 klo 12.36

Communiqué from the Annual General Meeting of STENOCARE

Stenocare
Third party research09.05.2025 klo 08.25

Analyst Group Comment on STENOCARE's Q1-report

STENOCARE A/S (STENOCARE or the “Company”) published on May 8th the Company’s Q1-report for 2025.

Stenocare